#CommunityPoll: We want to hear your thoughts! Are you planning on/currently recommending the use of #Doxycycline as Post-Exposure Prophylaxis for MSM on HIV PrEP and PLWH?

Is #DoxyPEP changing our PEP practices?

👀

Planning on coming out of my #Step2 dedicated time to review some of the amazing #IDWeek "Whats hot in ID" picks

I am returning to this project in 2024. Please let me know if you would be interested in participating! I am also thinking about starting a IM RCT Monthly Journal Club, anyone interested? We would discuss current RCTs and the conclusions would make it to the final analysis.

With the help of Gemini, I created an integrated tool to appraise Randomized Clinical Trials, taking the strongest features of the #RoB2, #CASP and #CEBM tools. It is freely available as a downloadable spreadsheet in the following link: docs.google.com/spreadsheets/d… @BayroNikolai

Discussing the VARSITY trial with Manuel Braga Neto during rounds today. "Big picture, Vedolizumab won". Would the results be different if the comparison was infliximab? Ref: N Engl J Med. 2019 Sep 26;381(13):1215-1226